or
forgot password
  • cancer clinical trials in phillipsburg, NJ

  • Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
    Warren Hospital
    Phillipsburg, New Jersey 08865
    Breast Cancer
    Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
    Warren Hospital
    Phillipsburg, New Jersey 08865
    Infection, Multiple Myeloma and Plasma Cell Neoplasm
    Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE)
    Warren Hospital
    Phillipsburg, New Jersey 08865
    Alzheimer Disease
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Warren Hospital
    Phillipsburg, New Jersey 08865
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Warren Hospital
    Phillipsburg, New Jersey 08865
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Warren Hospital
    Phillipsburg, New Jersey 08865
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer
    The Women's Institute for Gynecologic Cancer and Special Pelvic Surgery
    Phillipsburg, New Jersey 08865
    Endometrial Cancer
    Carboplatin, Paclitaxel and Gemcitabine With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
    The Women's Institute for Gynecologic Cancer and Special Pelvic Surgery
    Phillipsburg, New Jersey 08865
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer
    Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
    The Women's Institute for Gynecologic Cancer and Special Pelvic Surgery
    Phillipsburg, New Jersey 08865
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage IVB Cervical Cancer
    Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer
    Women's Institute for Gynecologic Cancer and Special Pelvic Surgery
    Phillipsburg, New Jersey 08865
    Endometrial Cancer, Fatigue, Neurotoxicity
    OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or Third Complete Remission
    The Women's Institute for Gynecologic Cancer and Special Pelvic Surgery
    Phillipsburg, New Jersey 08865
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer
    Women's Institute for Gynecologic Cancer and Special Pelvic Surgery
    Phillipsburg, New Jersey 08865
    Endometrial Cancer
    Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    The Women's Institute for Gynecologic Cancer and Special Pelvic Surgery
    Phillipsburg, New Jersey 08865
    Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Recurrent Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma
    Radiation Therapy With or Without Chemotherapy in Patients With Stage I or Stage II Cervical Cancer Who Previously Underwent Surgery
    Women's Institute for Gynecologic Cancer and Special Pelvic Surgery
    Phillipsburg, New Jersey 08865
    Cervical Cancer
    Cediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial Cancer
    The Women's Institute for Gynecologic Cancer and Special Pelvic Surgery
    Phillipsburg, New Jersey 08865
    Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Endometrial Papillary Serous Carcinoma, Recurrent Endometrial Carcinoma
    Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    The Women's Institute for Gynecologic Cancer and Special Pelvic Surgery
    Phillipsburg, New Jersey 08865
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    APF530 or Palonosetron Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer
    Star Hematology & Oncology
    Phillipsburg, New Jersey 08865
    Nausea and Vomiting, Unspecified Adult Solid Tumor, Protocol Specific
    APRiCOT-P: Study of Apricoxib With Gemcitabine and Erlotinib to Treat Advanced Pancreatic Cancer
    Warren Hospital
    Phillipsburg, New Jersey 08865
    Pancreatic Cancer, Metastatic Pancreatic Cancer